2m 2m 2m 2m 2m 2m 2m
SPERO THERAPETCS (SPRO)
NASDAQ
$1.14-$0.03 (-2.99%)
Price as of Oct 22, 2026 7:30 PM EDT- $68.1MMarket Cap
- -48.00%1-Year Change
- BiotechnologyIndustry
SPERO THERAPETCS (SPRO)
$1.14-$0.03 (-2.99%)
SPRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.17 | ||
Change | -$0.05 (-4.10%) | ||
Open | $1.21 | ||
High | $1.22 | ||
Low | $1.17 | ||
Previous Close | $1.22 | ||
Volume | 265,711 | ||
30-Day Average Volume | 848,590 | ||
1-Week Change | 4.46% | ||
1-Month Change | 2.63% | ||
1-Year Change | -48.00% | ||
3-Year Change | 9.35% | ||
5-Year Change | -93.01% | ||
Fundamentals | |||
Shares Outstanding | 58.2M | ||
Total Assets | $52.8M | ||
Market Cap | $68.1M | ||
Enterprise Value | $17.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$9.6M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$9.6M | ||
EBITDA | -$9.6M | ||
Net Working Capital | $43.2M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue